In medical treatment, the ratio of monotherapy was found to be about 80%, and it shows a decreasing trend compared to previous studies, and the rate of treatment with dual and triple drugs increases from 15.2% + 2.3% to 16.5% + 2.8%.
← all excerpts
Unveiling the Demographics and Clinical Characteristics of Diabetic Neuropathy: Findings From the National Health Insurance Service, 2012-2017.
1
—
—